TORRE, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 4.899
AS - Asia 422
NA - Nord America 247
SA - Sud America 41
AF - Africa 8
OC - Oceania 2
Totale 5.619
Nazione #
IT - Italia 4.839
US - Stati Uniti d'America 229
SG - Singapore 198
CN - Cina 106
VN - Vietnam 63
FR - Francia 36
BR - Brasile 26
BD - Bangladesh 19
HK - Hong Kong 14
CA - Canada 10
AR - Argentina 7
GB - Regno Unito 6
MX - Messico 5
NL - Olanda 5
FI - Finlandia 4
DE - Germania 3
IN - India 3
IQ - Iraq 3
KR - Corea 3
AU - Australia 2
EC - Ecuador 2
JO - Giordania 2
JP - Giappone 2
KE - Kenya 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GA - Gabon 1
IE - Irlanda 1
JM - Giamaica 1
LB - Libano 1
MD - Moldavia 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.619
Città #
Genova 3.013
Genoa 1.082
Rapallo 438
Vado Ligure 270
Singapore 84
San Jose 66
Ashburn 35
Lauterbourg 33
New York 23
Ho Chi Minh City 17
Beijing 14
Hong Kong 14
Santa Clara 12
Hanoi 11
Amsterdam 5
Bordighera 5
Los Angeles 5
Helsinki 4
Mexico City 4
Tianjin 4
Da Nang 3
Montreal 3
Buffalo 2
Bình Dương 2
Bắc Ninh 2
Cagayan de Oro 2
Chicago 2
City of London 2
Dallas 2
Detroit 2
London 2
Mumbai 2
Nairobi 2
Orem 2
Paris 2
Phoenix 2
Quảng Ngãi 2
Rome 2
São Paulo 2
Toronto 2
Addis Ababa 1
Al Kazimiyah 1
Al Maḩallah al Kubrá 1
Alpharetta 1
Amman 1
Andover 1
Antakya 1
Asunción 1
Atlanta 1
Baku 1
Barbacena 1
Bengaluru 1
Biên Hòa 1
Bloomfield 1
Boynton Beach 1
Bragado 1
Brasília 1
Brescia 1
Bucheon-si 1
Bình Phước 1
Bắc Giang 1
Cabo Frio 1
Cachoeirinha 1
Cagliari 1
Camilla 1
Campinas 1
Candelo 1
Cantanhede 1
Cardiff 1
Carlsbad 1
Casablanca 1
Casteldaccia 1
Chaguanas 1
Changsha 1
Charata 1
Chino Hills 1
Cotia 1
Da Lat 1
Davie 1
DeLand 1
Decatur 1
Denver 1
Des Moines 1
Doha 1
Dublin 1
Durban 1
Encarnación 1
Esmeraldas 1
Florianópolis 1
Frankfurt am Main 1
Ft. Pierce 1
Ghermănești 1
Gravataí 1
Grünstadt 1
Guangzhou 1
Guarulhos 1
Hualien City 1
Ibiúna 1
Ipaussu 1
Istrana 1
Totale 5.241
Nome #
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 220
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 220
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. 219
Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity. 176
Circadian secretion of melatonin and thyrotropin in hospitalized aged patients. 176
Peripheral blood serum markers for apoptosis and liver fibrosis: Are they trustworthy indicators of liver realness? 170
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. 163
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 158
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use 157
Clinical implications of mutations in the hepatitis B virus genome. 156
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 156
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 153
Clearance kinetics of hepatitis C virus under different antiviral therapies. 153
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden 148
Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia. 147
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis. 144
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: a region-wide survey in Italy 142
Evolution of wild-type and precore mutant HBV infection after liver transplantation. 140
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C 140
Course of oesophageal varices and performance of non-invasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease 139
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients. 135
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients 133
Elevations in ALT levels late the course of antiviral therapy in HCV-RNA negative patients are associated with virological relapse 130
Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. 129
TT virus infection in haemodialysis patients 128
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin. 127
Chronic hepatitis C. New therapeutic strategies. 127
Erythrocytes cell wall defects correlate with the stage of liver cirrhosis 127
Prospective evaluation of primary infection due to HCV, HGV or TTV in children with newly diagnosed neoplasia. 126
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C 123
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant 122
Amantadine: a different approach. 122
Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. 120
Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. 116
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. 114
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. 107
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients 102
Evaluation of a new hepatitis C virus sequecing assay as a routine method for genotyping 102
Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs. 97
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment. 76
Totale 5.640
Categoria #
all - tutte 16.100
article - articoli 16.100
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022453 13 26 27 46 17 42 31 112 21 56 14 48
2022/2023536 59 58 7 45 81 90 3 48 86 5 48 6
2023/2024224 7 37 3 31 22 34 5 8 13 1 28 35
2024/2025729 30 43 11 54 96 57 59 150 17 26 80 106
2025/20261.119 177 30 44 76 177 83 166 56 95 101 71 43
Totale 5.640